Ragini Kudchadkar, MD, discusses the overall prognosis of patients with ocular melanoma.
Ragini Kudchadkar, MD
Advertisement
Articles by Ragini Kudchadkar, MD
Ragini Kudchadkar, MD, discusses the benefits of combining BRAF and MEK inhibitors when treating melanoma.
Ragini Kudchadkar, MD, assistant professor, medical oncology, Moffitt Cancer Center, discusses testing in patients with melanoma.
Advertisement
Latest Updated Articles
Testing Patients With MelanomaPublished: October 11th 2013 | Updated:
Combining BRAF and MEK Inhibitors to Treat MelanomaPublished: November 6th 2013 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
